US › Healthcare

Tonix Pharmaceuticals Holding Corp (TNXP)

US · Healthcare · Biotechnology

$11.21+5.11%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$6.9M
Revenue YoY
+183.2%
Net profit
$-40.2M
Profit YoY
-138.8%
EPS
$-2.93
EPS estimate
$-2.54
Net margin
-584.4%

EPS came in at -2.93 against a street estimate of -2.54 — a miss of 15.4%.

Key statistics

Market cap
$151.6M
Forward P/E
0.0
P/B
0.70
Book value
$15.99
EPS (TTM)
$-14.00
52-week high
$69.97
52-week low
$9.40
50-day MA
$11.97
200-day MA
$14.92
Beta
1.65

Analyst view

Analysts rate Tonix Pharmaceuticals Holding Corp a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $42.20.

Shareholding

Insiders
0.14%
Institutions
45.89%

Largest institutional holders

FundStake
BlackRock Inc6.07%
Vanguard Group Inc4.23%
Vanguard Capital Management, LLC3.25%
Citadel Advisors Llc2.94%
Jones Hill Capital LP2.84%
Geode Capital Management, LLC1.97%
Balyasny Asset Management LLC1.96%
UBS Group AG1.45%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Tonix Pharmaceuticals Holding Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.